Processa Pharmaceuticals Other Long Term Assets (Quarterly) Analysis

Processa Pharmaceuticals, Inc. (PCSA)

2.10 -0.18 (-7.89%) USD | NASDAQ | Feb 20, 16:00

2.00 -0.10 (-4.76%) After-Hours: 20:00

View Other Long Term Assets (Quarterly) for PCSA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Assets (Quarterly) Benchmarks

Start Trial

Kodiak Sciences, Inc.	Upgrade
Pyxis Oncology, Inc.	--
ACADIA Pharmaceuticals, Inc.	Upgrade
Alnylam Pharmaceuticals, Inc.	Upgrade
Savara, Inc.	Upgrade